Dan McCormick

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada.

Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC.

MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.

Morton Grove Pharmaceuticals, Inc. develops, manufactures, and markets liquid pharmaceuticals. Its products include Benadryl, corticosteroid prednisolone, and fluoxetine. The firm distributes its products through wholesalers, chain drug stores, and retailers. The company was founded by Brian Tambi in 1995 and is headquartered in Morton Grove, IL.

EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI.

GP2U Telehealth Pty Ltd. provides an online doctor service for diagnosis, immediate prescription, specialist referral, and medical certificate aspects. The company offers a telemedicine solution for specialists, corporates, and residential aged care facilities. It serves patients in Australia. The company was founded by James Freeman in 2011 and is headquartered in Battery Point, Australia.

Part of DATIX (Holdings) Ltd., Porzio Life Sciences LLC is a leading provider of compliance solutions to the life sciences industry. The company is based in Morristown, NJ. The company, a wholly owned subsidiary of Porzio, Bromberg & Newman PC, was established in 2004 and has since developed regulatory compliance software for pharmaceutical manufacturers. Porzio Life Sciences licenses its software to more than 600 pharmaceutical companies globally and serves over 500 pharmaceutical, biotech, and medical device company customers. The CEO of the company is Vito A. Gagliardi. Porzio Life Sciences was acquired by RLDatix Ltd. from Porzio, Bromberg & Newman PC on November 01, 2022.

8chili, Inc. is a deep tech company based in Emeryville, CA. The company is building the underlying infrastructure for metaverse content creation and distribution through their device agnostic platform, hintvr™. This platform enables the creation, customization, and distribution of original 3D content across various metaverse estates, solving the problem of reach and content for organizations looking to offer services to their metaverse users. hintvr™ makes 3D content creation easy and provides a cloud-based content authoring platform. The company was founded by Amit Vohra and Abhita Batra, and the CEO is Aravind Upadhyaya.

Neuro42, Inc. is a medical technology company based in California that focuses on diagnostic imaging and image-guided surgical interventions of the brain. Neuro42 is developing and commercializing a portable, intraoperative MR, AI, and robotic platform that allows easy access to MR imaging for screening, diagnosis, and interventions of neurological diseases. The American company's platform is backed by over 40 patents and is poised to enhance patient and physician experience with its novel, easy-to-use, and portable configuration. The company was founded by Abhita Batra, Amit Vohra, and Dinesh Kumar, and Amit Vohra has been the CEO since incorporation.

MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong.